UPCOMING EVENTS
“CURRENT FDA CBER REGULATORY INITIATIVES and PDA DEL VAL VENDOR NIGHT”
Wednesday, October 16, 2024
DESCRIPTION OF MEETING: Join the PDA DEL VAL membership for our meeting entitled, “Current FDA CBER Initiatives” coupled with our Annual Vendor Night Extravaganza at the Desmond Hotel and Convention Center in Malvern, PA.
The evening will start with our Annual Vendor Night Extravaganza which will feature 40 vendors displays in the Foyer and Main Room of the Desmond Hotel. Included will be food stations, beverages, a cash bar and 40 vendor raffles. Per the schedule below, the presentation on “Current FDA Initiatives” will be conducted in the Amphitheater of the Desmond Hotel (3rd Floor of Conference Center). This presentation will focus on what current and upcoming FDA Center for Biologics (CBER) initiatives exist in the industry relating to sterile manufacturing and testing operations. This is a must-see presentation and please register early as space will be limited. More Information to be posted soon.
SPEAKER:
Daniel DeCiero, Consumer Safety Officer, OCBQ, CBER, U.S. FDA
PRESENTATION DESCRIPTION:
Join us for an update on the latest compliance and quality trends shaping the industry's regulatory landscape under CBER. The session provides insights into pivotal areas currently drawing CBER's regulatory focus.
Discover the latest enforcement actions, including Warning Letters, Untitled Letters, and “It Has Come to Our Attention” letters issued since September 2023. You will have the opportunity to gain valuable insights into new areas of product development and better understand the regulatory expectations for manufacturers of CBER-regulated products, particularly in the realm of regenerative medicine therapies. The session will explore the regulatory framework governing these therapies, providing clarity on FDA enforcement strategies and the evolving compliance landscape.
We will also discuss notable quality challenges observed in licensed biological product manufacturing, such as microbial and particulate contamination control, and critical issues surrounding component quality.
Don't miss this opportunity to stay ahead of the curve and ensure your compliance strategies align with the latest regulatory expectations.
SPEAKER BIO:
Dan DeCiero is the Branch Chief of the Biological Drug and Device Compliance
Branch in CBER’s Office of Compliance Biologics Quality (OCBQ). This office
performs reviews and evaluations of compliance and enforcement actions for
biological products, drugs and devices regulated by CBER. He has been in CBER
since 2019 and has been at the Agency since 2015. Previously, he was a
Process and Facilities reviewer in CDER’s Office of Process and Facilities. In this
role, he assessed proposed manufacturing and testing processes for filed drug
applications (ANDA/NDA), including performing and assessing pre-approval
inspections for related manufacturing facilities. Prior to joining FDA, he worked in
systems engineering at General Dynamics and at Merck performing laboratory
and pilot-plant scale development of APIs. He has a M.S. degree in Regulatory
Science from the University of Maryland Baltimore and a B.S. degree in Chemical
Engineering from Worcester Polytechnic Institute.
DATE:
Wednesday, October 16, 2024
TIME:
4:00-7:15: Networking, food stations, beverages, a cash bar and vendor raffles in Exhibit Hall
7:30-9:00: Presentation
LOCATION:
Desmond Hotel and Convention Center, Malvern, PA 19355
TICKET PRICE: $80.00
Register to this Event:PAST EVENTS
“Contamination Control Panel Discussion and the PDA Delaware Valley Science Fair Finalists Displays”
Tuesday, June 18, 2024
DESCRIPTION OF MEETING: “Contamination Control Panel Discussion and the PDA Delaware Valley Science Fair Finalists Displays”
SPEAKER/PANEL:
Angel Salaman - Principal Scientist, Microbiology Subject Matter Expert/Quality Assurance - Janssen Biotech, Inc.
Art Vellutato, Jr. - President/CEO/Senior API Consultant- Veltek Associates, Inc. and Aseptic Processing, Inc.
Chris Smalley - Pharmaceutical and Compounding Pharmacy Consultant, ValSource, Inc.
Leo Posner - Moderator - Quality Head - JSC Stability Operations - Johnson & Johnson
Stephen Yang – Director, Microbial Quality and Sterility Assurance, Merck & Co.
OVERVIEW OF PANEL DISCUSSION:
Controlling contamination is a function that spans virtually throughout every sector of a GMP manufacturing and/or testing operation. The complexity of personnel gowning, incoming component entry, product contact component cleaning and sterilization, non-product surface cleaning and disinfection, cleaning and disinfection of structures and equipment, disinfectant efficacy performance, particulate removal and identification, environmental monitoring, tracing contamination, conducting investigations and meeting worldwide regulatory requirements will all be discussed in detail. This panel will delve into the complicated and critical areas that are required to assure product and patient safety as well as addressing domestic and foreign regulatory concerns.
SPECIAL EVENT:
The PDA Delaware Valley Science Fair has been supported by the Delaware Valley Chapter of PDA for over 30 years. As judged by the PDA Planning Committee, the finalists and their families will all be in attendance with their displays in the foyer and relate to the entire assembly a summary of their science project and results. These amazing kids are the next generation of scientists in our world. Come support their efforts.
DATE:
Tuesday, June 18, 2024
TIME:
5:00-6:00: Networking and Cash Bar – PDA Delaware Valley Student Science Fair Displays
6:00-7:30: Dinner Buffet
7:30-9:00: Presentation
LOCATION:
Desmond Hotel and Convention Center, Malvern, PA 19355
Click here to send in advance the questions you would like to ask us during the event.
TICKET PRICE: $80.00
Register to this Event:Infection Prevention through Sterility Assurance & Microbiological Quality: Reflections from a Patient & Industry SME
Tuesday, April 9, 2024
DESCRIPTION OF MEETING: “Infection Prevention through Sterility Assurance & Microbiological Quality: Reflections from a Patient & Industry SME”
SPEAKER:
Dawn Nestola, Director Sterility Assurance & Microbiological Quality, GlazoSmithKline.
OVERVIEW OF PRESENTATION:
Sterility assurance and microbiological quality (SA & MQ) are fundamental to the production of pharmaceuticals/biopharmaceuticals, advanced therapy medicinal products (ATMPs), medical devices, and over-the-counter (OTC) medicines, contributing to product quality, safety, and promoting infection prevention in patients and consumers.
Recent updates to EU Annex 1 have mandated that manufacturers develop and actively maintain a robust contamination control strategy (CCS), and end-to-end SA & MQ are core to this regulatory requirement. Although a CCS primarily focuses on activities directly controlled by a manufacturer, elements that extend beyond the bounds of a GMP facility's four walls are just as important. In fact, SA & MQ begin elsewhere, with suppliers and sub-suppliers who provide, for example, device components and subcomponents, packaging components, manufacturing consumables (often sterile single-use systems), sterilization services, and raw materials, including aseptically collected patient cells (via apheresis), which may be the primary raw material in an ATMP. Likewise, SA & MQ do not terminate when a released product leaves the manufacturing facility, bound for a distribution center or customer. In contrast, SA & MQ end with each successful patient or consumer outcome when a product of appropriate microbiological quality (for its intended use) is consumed and/or properly used by the medical practitioner or recipient.
The speaker's presentation will focus on her patient experience with a life-threatening medical condition and offer reflections, through the lens of an industry SME, on her treatment journey and how SA & MQ contributed to her positive patient outcome.
SPEAKER BIO:
Dawn’s 24-year career as a microbiologist has been entirely focused on infection prevention through microbiological quality and sterility assurance. She is experienced in contamination control in the manufacture of sterile, low bioburden and non-sterile products, medical device development and associated clinical processing, and medical device sterilization.
Dawn presently works for GSK as Director of Sterility Assurance & Micriobiological Quality. Prior industry experience includes positions with Johnson & Johnson (McNeil and DePuy Synthes), Pfizer, and Pharmacia. She also enjoyed time as an adjunct professor teaching an accredited college level course on the fundamentals of aseptic processing. Dawn earned a Bachelor of Science degree in Microbiology from Michigan State University and holds a Master of Business Administration degree from Centenary University.
DATE:
Tuesday, April 9, 2024
TIME:
5:30-6:30: Networking Reception
6:30-8:00: Dinner in Main Ballroom
8:00-9:15: Presentation
LOCATION:
Desmond Hotel and Convention Center, Malvern, PA 19355
TICKET PRICE: $80.00
Register to this Event:VENDOR NIGHT and “Current Regulatory Initiatives”
October 17, 2023
DESCRIPTION OF MEETING: Join the PDA DEL VAL membership for our meeting entitled, “Current FDA Initiatives” coupled with our Annual Vendor Night Extravaganza at the Desmond Hotel and Convention Center in Malvern, PA.
The evening will start with our Annual Vendor Night Extravaganza which will feature 40 vendors displays in the Foyer and Main Room of the Desmond Hotel. Included will be food stations, beverages, a cash bar and 40 vendor raffles. Per the schedule below, the presentation on “Current FDA Initiatives” will be conducted in the Amphitheater of the Desmond Hotel (3rd Floor of Conference Center). This presentation will focus on what current and upcoming FDA initiatives exist in the industry relating to sterile manufacturing and testing operations. This is a must-see presentation and please register early as space will be limited. More Information to be posted soon.
Speaker:
Tamara Ely
FDA Branch Chief, Division of Drug Quality II, Office of Manufacturing Quality, Office of Compliance, CDER
Date:
Tuesday, October 17, 2023
Time:
4:00-7:15: Networking, food stations, beverages, a cash bar and vendor raffles in Exhibit Hall
7:30-9:00: Presentation
Location:
Desmond Hotel and Convention Center, Malvern, PA 19355
Ticket Price: $80.00
Register to this Event:Complying with EU GMP Annex 1:
How are GMP Organizations Complying with Released Guidance?
DESCRIPTION OF MEETING: Join the PDA DEL VAL membership for a Dinner Meeting at the Desmond Hotel and Convention Center in Malvern, PA for a panel discussion surrounding the review and implementation of the new EU GMP Annex 1, Manufacture of Sterile Medicinal Products into operations. This meeting will include panel participants from GMP organizations who are currently implementing strategies to meet the requirements in the newly released guidance documents. This moderated session will include the ability of the audience to ask the panelists pertinent questions as to how they and their organization are addressing each phase of the released guidance. The basis of the meeting is for GMP organizations to learn from other GMP organizations on how they may be implementing the needed and required attributes to comply with the guidance.
Panelists/Moderator:
Pat Bailey - Merck & Company
Angel Salaman - Janssen Pharmaceuticals
Mitch Garber - 2seventybio
Art Vellutato, Jr. – Veltek Associates, Inc. – Moderator
Date:
Wednesday, April 19, 2023
Time:
5:00-6:00: Networking and Cash Bar
6:00-7:30: Dinner Buffet
7:30-9:00: Presentation
Location:
Desmond Hotel and Convention Center, Malvern, PA 19355
Ticket Price: $80.00
JIT FOR CAR-T AND PTC FOR GENE THERAPY APPLICATIONS AND
THE PDA DELAWARE VALLEY SCIENCE FAIR
Finalists Displays:
DESCRIPTION OF MEETING: Currently CAR T products typically represent the final treatment option for patients suffering from various forms of cancer. It is critical that CAR T products are manufactured and returned to the patient in an expedited manner. To achieve this goal, manufacturers of CAR T products must adopt and utilize Quality Risk Management (QRM) principles during manufacture, testing, and release. Risk based contamination control strategies must be employed from apheresis collection through final product release. A risk assessment, encompassing each step of the manufacturing process, should be performed to highlight potential areas of microbial ingress. Where possible, mitigating actions must be implemented to eliminate risk or reduce risk to an acceptable risk level. Based on a well-defined and documented microbial contamination control strategy, it should be possible for manufacturers to implement a just-in-time microbiological release strategy. This meeting will highlight microbial contamination control and testing risks that can be identified throughout each stage of the manufacturing process that will allow for a potential just in time release of CAR T products.
SPECIAL EVENT: The PDA Delaware Valley Science Fair has been supported by the Delaware Valley Chapter of PDA for over 30 years. As judged by the PDA Planning Committee, the finalists and their families will all be in attendance with their displays in the foyer and relate to the entire assembly a summary of their science project and results. These amazing kids are the next generation of scientists in our world. Come support their efforts.
Speakers:
Katrina Hosbach - Adaptimmune
Date:
Thursday, June 15, 2023
Time:
5:00-6:00: Networking and Cash Bar – PDA Delaware Valley Student Science Fair Displays
6:00-7:30: Dinner Buffet
7:30-9:00: Presentation
Location:
Desmond Hotel and Convention Center, Malvern, PA 19355
Ticket Price: $80.00
To stay up to date on where we have been, visit our Past Events page
BECOME A SPONSOR
Gain access to over 2,000 industry professionals by becoming a sponsor of PDA Delaware Valley!
EVENTS
Check out our Events Calendar! With events ranging from breakfast symposiums to vendor nights to science fairs, we cater to the entire industry!
CONTACT US
For more information on chapter activities, please send your query to contact@pdadelval.org